Apoptosis, autophagy, ferroptosis, and pyroptosis in cisplatin-induced ototoxicity and protective agents
Cisplatin is widely used to treat various solid tumors. However, its toxicity to normal tissues limits its clinical application, particularly due to its ototoxic effects, which can result in hearing loss in patients undergoing chemotherapy. While significant progress has been made in preclinical stu...
Saved in:
Main Authors: | Dingyuan Dai (Author), Chao Chen (Author), Chen Lu (Author), Yu Guo (Author), Qi Li (Author), Chen Sun (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity
by: Eri Wakai, et al.
Published: (2022) -
Current Strategies to Combat Cisplatin-Induced Ototoxicity
by: Dehong Yu, et al.
Published: (2020) -
Programmed Cell Death in Asthma: Apoptosis, Autophagy, Pyroptosis, Ferroptosis, and Necroptosis
by: Liu L, et al.
Published: (2023) -
Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo
by: Benyu Nan, et al.
Published: (2022) -
Glutathione metabolism rewiring protects renal tubule cells against cisplatin-induced apoptosis and ferroptosis
by: Xing-Qiang Dong, et al.
Published: (2023)